Low incidence of COVID-19 in hidradenitis suppurativa: How to interpret it?
Exp Dermatol
.
2022 Mar;31(3):435-436.
doi: 10.1111/exd.14475.
Epub 2021 Nov 3.
Authors
Mathilde Dewigne
1
,
Carmen Orte Cano
1
,
Mathieu Daoud
1
2
,
Véronique Del Marmol
1
2
,
Farida Benhadou
1
2
Affiliations
1
Dermatology Department, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.
2
European Hidradenitis Suppurativa Foundation e.V, Dessau, Germany.
PMID:
34679208
PMCID:
PMC8652693
DOI:
10.1111/exd.14475
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
COVID-19*
Hidradenitis Suppurativa* / epidemiology
Hidradenitis Suppurativa* / etiology
Humans
Incidence
SARS-CoV-2
Grants and funding
Academic grant for COVID-19 research/Fonds Erasme